Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis

Ruchir Gupta1,2, Mara L Leimanis1,3, Marie Adams4

  • 1Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.

Insights

This study reveals distinct immune system signatures in infants with severe acute bronchiolitis, identifying sex differences and unique patient responses. Understanding these viral infection patterns improves healthcare delivery.

Area of Science:

  • Pediatric infectious diseases
  • Molecular biology
  • Genomics

Background:

  • Lower respiratory tract viral infections pose significant healthcare burdens.
  • Lack of vaccines and antivirals necessitates better risk factor and outcome analysis.
  • Minimally invasive methods like blood analysis can improve patient care.

Purpose of the Study:

  • To investigate transcriptomic signatures in infants with acute bronchiolitis.
  • To identify molecular differences between moderate and severe cases.
  • To explore sex-based variations in gene expression related to disease severity.

Main Methods:

  • Utilized PAXgene RNA sequencing on infant cohorts with acute bronchiolitis.
  • Employed case-control statistical analysis and cohort-based outlier mapping.
  • Focused on precision transcriptomics for identifying molecular patterns.

Main Results:

  • Severe bronchiolitis showed distinct immune, interferon, and cytokine signaling signatures.
  • Significant sex differences were observed in specific gene expressions (XIST, RPS4Y1, KDM5D, LINC00278).
  • Identified unique secondary infections, cytokine activation, and immune responses in individual patients.

Conclusions:

  • Patient-level transcriptomic signatures are crucial for understanding adverse outcomes in viral bronchiolitis.
  • Integrating cohort biomarkers with individual biological responses is essential.
  • Precision medicine approaches can enhance healthcare for viral respiratory infections.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
615
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
522
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
270
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
453
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
522